Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

November 16 2017 Scotland’s new General Medical Services contract could “reduce...

BMA sets out case for ‘Saving General Practice’

BMA sets out case for ‘Saving General Practice’

November 15 2017 The British Medical Association has published a list of areas it says need...

Scottish out of hours date indicates 950,000 primary care consultations in 2016-17

Scottish out of hours date indicates 950,000 primary care consultations in 2016-17

November 1 2017 Around 850,00 patients contacted out of hours (OOH) care services in primary care...

Hospital checks on treatment entitlement could swell GP caseload

Hospital checks on treatment entitlement could swell GP caseload

October 23 2017 New regulations requiring hospitals to charge people upfront if the patient...

Scotland urges parents to take young children to GPs for flu vaccination

Scotland urges parents to take young children to GPs for flu vaccination

October 6 2017 Parents in Scotland are being urged to have their children aged 2-5 years...

  • Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

    Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

    Thursday, 16 November 2017 18:16
  • BMA sets out case for ‘Saving General Practice’

    BMA sets out case for ‘Saving General Practice’

    Wednesday, 15 November 2017 10:52
  • Scottish out of hours date indicates 950,000 primary care consultations in 2016-17

    Scottish out of hours date indicates 950,000 primary care consultations in 2016-17

    Wednesday, 01 November 2017 10:52
  • Hospital checks on treatment entitlement could swell GP caseload

    Hospital checks on treatment entitlement could swell GP caseload

    Monday, 23 October 2017 11:00
  • Scotland urges parents to take young children to GPs for flu vaccination

    Scotland urges parents to take young children to GPs for flu vaccination

    Friday, 06 October 2017 16:39

adhdDecember 2 2015

Researchers have urged doctors to be cautious if considering prescribing methylphenidate for children or adolescents with attention deficit hyperactivity disorder (ADHD).

A Cochrane review has concluded that the drug may improve teacher-reported ADHD symptoms, teacher-reported general behaviour, and parent-reported quality of life among children and adolescents diagnosed with ADHD. “However, the low quality of the underpinning evidence means that we cannot be certain of the magnitude of the effects.”

The researchers assessed 38 parallel-group trials and 147 cross-over trials, representing over 12,200 patients, and found methylphenidate led to “modest” improvements in ADHD symptoms as a primary outcome. They also found there were improvements in general behaviour and quality of life. However, in all outcomes, the quality of the evidence was judged to be “very low”.

Data for serious adverse events was only reported in nine out of the 185 trials, meaning that while methylphenidate does not appear to be associated with an increased risk of serious adverse events, the quality of the evidence was again very low.

“It was apparent from assessing the included trials that it would have been possible for people involved in the trials to have been aware of which treatment the children were taking,” says Cochrane. “In addition, the reporting of results was not complete in many of the trials, and for some analyses there was variation among trial results.

“Based upon this information, the researchers urge clinicians to be cautious in prescribing methylphenidate, and to weigh up the benefits and risks more carefully.”

Professor Ole Jakob Storebø, a clinical psychologist from the Psychiatric Research Unit in Region Zealand, Denmark, led the team of 18 researchers carrying out the meta-analysis. “This review highlights the need for long-term, large, better-quality randomized trials so that we can determine the average effect of this drug more reliably,” he said.

Co-author Camilla Groth MD added: “This review shows very limited quality evidence for the effects of methylphenidate on children and adolescents with ADHD. Some might benefit, but we still don’t know which patients will do so. Clinicians prescribing methylphenidate must take account of the poor quality of the evidence, monitor treatment carefully, and weigh up the benefits and adverse effects.”

Links:

Cochrane announcement

Cochrane review summary

Ole Jakob Storebø et al. ‘Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)’. Cochrane Library. Published online November 25 2015.

Contract News

November 16 2017 Scotland’s new General Medical Services contract could “reduce workload pressures and re-establish general practice as an attractive career choice,” the BMA has...
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...